India  

Pfizer vaccine is 94% effective in real-world study

Video Credit: Reuters Studio - Duration: 01:47s - Published
Pfizer vaccine is 94% effective in real-world study

Pfizer vaccine is 94% effective in real-world study

The first big real-world study of the Pfizer/BioNTech vaccine to be independently reviewed shows the shot is highly effective at preventing COVID-19, in a potentially landmark moment for countries desperate to end lockdowns and reopen economies.

Gloria Tso reports.


You Might Like


💡 newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

President Joe Biden tests positive for COVID-19 [Video]

President Joe Biden tests positive for COVID-19

Credit: FRANCE 24 English    Duration: 01:51Published
US President Biden tests positive for COVID amid growing health concerns [Video]

US President Biden tests positive for COVID amid growing health concerns

As pressure mounts on Biden to drop his re-election campaign, he revealed that he tested positive for COVID-19 before cancelling his speech for an event in Las Vegas.

Credit: euronews (in English)    Duration: 01:14Published

UK public 'failed' by governments which prepared for 'wrong pandemic' ahead of COVID-19, inquiry finds

The UK's citizens were "failed" by their governments' processes, planning and policy ahead of the COVID-19 pandemic, a public inquiry has concluded.
Sky News
Biden Hits Pause on his Campaign Trail As Covid-19 Diagnosis Leads to Delaware Quarantine| Watch [Video]

Biden Hits Pause on his Campaign Trail As Covid-19 Diagnosis Leads to Delaware Quarantine| Watch

President Joe Biden, 81, tested positive for Covid-19 during a Las Vegas campaign trip. He's experiencing mild symptoms and will self-isolate in Delaware. This health setback comes amid mounting pressure from fellow Democrats urging him to withdraw from the 2024 presidential race, citing age concerns and electability issues. Recent polls show significant numbers of Democratic and independent voters believe Biden should step aside. #JoeBiden #Biden2024 #PresidentBiden #Delaware #COVID19 #BidenHealth Trump2024 #DonaldTrump #USnews #USpolitics #Worldnews #RNC #Oneindia #Oneindianews ~PR.320~HT.318~ED.194~GR.125~

Credit: Oneindia    Duration: 03:09Published

President Biden Tests Positive for COVID, Public Appearance Canceled

President Joe Biden's got the 'rona -- 'cause he just tested positive for COVID-19 ... and as a result, his public appearances are being put on pause. The news..
TMZ.com

Related news from verified sources

Coronavirus | Large real world study confirms Pfizer COVID-19 vaccine 94% effective

The study finds out that people who received their second dose of the vaccine had a 92% lower chance...
Hindu - Published

Pfizer's COVID-19 vaccine found effective in big 'real world' test, prevents illness and death

Pfizer's COVID-19 vaccine was 92% effective at preventing severe disease after two shots and 62%...
Zee News - Published


Related videos from verified sources

Pfizer Is Studying the Effects of a Third COVID-19 Vaccine Dose [Video]

Pfizer Is Studying the Effects of a Third COVID-19 Vaccine Dose

Pfizer Is Studying the Effects of a Third COVID-19 Vaccine Dose. Two doses of Pfizer's COVID-19 vaccine have proven to be 95% effective at preventing severe coronavirus infection. On Feb. 25, the..

Credit: Wibbitz Top Stories     Duration: 01:05Published
UK to Expose Healthy Volunteers to COVID in World’s First ‘Human Challenge’ Study [Video]

UK to Expose Healthy Volunteers to COVID in World’s First ‘Human Challenge’ Study

UK to Expose Healthy Volunteers to COVID in World’s First ‘Human Challenge’ Study. On Feb. 17, the country's Department for Business, Energy and Industrial Strategy (BEIS) revealed that the..

Credit: Wibbitz Top Stories     Duration: 01:11Published
Promising data in Israel's vaccine race [Video]

Promising data in Israel's vaccine race

Israel’s swift vaccination rollout has made it the largest real-world study of Pfizer Inc’s COVID-19 vaccine. Results are trickling in, and they are promising, Megan Revell reports.

Credit: Reuters Studio     Duration: 03:04Published